Skip to main content
Caplight Logo









NeurekaLAB

NeurekaLAB

Private
BarcelonaHealthcare & Life Scienceshttps://neurekalab.com/es/inicio/

Last Round

Grant

May 5, 2026

Total Funding Raised

$88,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

NeurekaLAB operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a Grant round in May 2026.

NeurekaLAB is an EdTech company that develops gamified digital tools for the early detection and intervention of learning difficulties such as dyslexia, dyscalculia, and ADHD in children.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

NeurekaLAB Comparables

Compare NeurekaLAB with similar companies based on industry and business-model similarity.

NeurekaLAB comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Change Dyslexia
88%
Dynamo Maths
82%
Glifing, S.L.
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

NeurekaLAB Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 5, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

NeurekaLAB Investors

Notable investors and investment history

NeurekaLAB investors
InvestorRounds
Bikai Venture PhilanthropyGrant
Ship2BGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 5, 2026

    Secured $88K from Bikai Venture Philanthropy and Ship2B.

  • Jun 1, 2025

    Monthly visitors increased 59% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

NeurekaLAB Filings

Explore SEC and related filing metadata, where available.

NeurekaLAB filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about NeurekaLAB's valuation, stock price, and market status.

Is NeurekaLAB a public or private company?

NeurekaLAB is a private company.

What is the current stock price of NeurekaLAB?

NeurekaLAB is a private company, so its shares have no public market price. Caplight tracks NeurekaLAB's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is NeurekaLAB worth (valuation)?

Valuation information for NeurekaLAB is not publicly available.

Can I buy NeurekaLAB stock?

NeurekaLAB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was NeurekaLAB's last funding round?

NeurekaLAB's most recent funding round was Grant on May 5, 2026.

Who are the main investors in NeurekaLAB?

Key investors in NeurekaLAB include Bikai Venture Philanthropy, Ship2B.

Will NeurekaLAB IPO soon?

No public IPO plans have been announced for NeurekaLAB.

How can I track NeurekaLAB secondary market activity?

Caplight tracks bids, offers, and trades in NeurekaLAB's shares on secondary markets.

Firmographic Details

HeadquartersBarcelona
Employee Range5
Year Founded2019
Last FundingMay 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?